Serum levels of neopterin during antimicrobial treatment for Mycobacterium ulcerans infection. - Wikidata - awgldk - TriplyDB

Serum levels of neopterin during antimicrobial treatment for Mycobacterium ulcerans infection.

Serum levels of neopterin during antimicrobial treatment for Mycobacterium ulcerans infection.

http://www.wikidata.org/entity/Q37166129

about

Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer Urinary neopterin levels increase and predict survival during a respiratory outbreak in wild chimpanzees (Taï National Park, Côte d'Ivoire)

P2860

Q35994923-1007A056-51BA-4235-B1B2-9E116C038473 Q58761909-48C3214A-FFF1-4C73-A38F-18C85F77FBAC

P2860

Serum levels of neopterin during antimicrobial treatment for Mycobacterium ulcerans infection.

http://www.wikidata.org/entity/Q37166129

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum levels of neopterin duri ...... obacterium ulcerans infection.

@en

Serum levels of neopterin duri ...... obacterium ulcerans infection.

@nl

type

label

Serum levels of neopterin duri ...... obacterium ulcerans infection.

@en

Serum levels of neopterin duri ...... obacterium ulcerans infection.

@nl

prefLabel

Serum levels of neopterin duri ...... obacterium ulcerans infection.

@en

Serum levels of neopterin duri ...... obacterium ulcerans infection.

@nl

P1433

Q37166129-2C8B2A2D-4F23-46C1-B0A7-78CB0EBFF0F9

P1476

Q37166129-18F7B24E-43A6-4EA2-89E1-2F72D0D744AA

P2093

Q37166129-36D94E78-52E8-4D3E-86F2-75D559BE6FBC

Q37166129-3BFC5413-8448-4752-A632-EBE217BD1974

Q37166129-4215B7C3-C956-4345-957C-E0177CA87B0F

Q37166129-5D4FB0D1-8250-48F0-A0E6-222296BC3D38

Q37166129-91FD47A8-5154-4B20-802E-A03A7CC84A60

Q37166129-FFB6E1D5-7BF1-4B2B-9F3B-E8BF1A4A62B8

P2860

Q37166129-2E47C768-179B-4F44-B458-A60D6A16ADE3

Q37166129-363CB3C1-7461-4531-A8A2-C1A0AA7D797A

Q37166129-3BAB2805-6F69-42BF-BD72-0ECD3563815D

Q37166129-648D6010-FD49-44CD-B999-2725AF99E023

Q37166129-80738859-5852-464F-9A0C-BB789683A48E

Q37166129-98B1AA9E-114A-4C68-A0DE-65AAF7C419E7

Q37166129-C82835E3-33AD-47AF-85F3-33B547747A5F

Q37166129-D673A157-22F0-4939-BE48-4C8B6C500563

Q37166129-DEEB6377-4170-42CB-95DE-B8AB7E00AE76

Q37166129-FA9A9C0E-870C-4ABD-8AE1-221D2D06890D

P304

Q37166129-F2619A69-4E9D-4288-8C87-5A082570E06B

P31

Q37166129-62FBB3E6-9391-4553-94A4-FB9D46FDC2D0

P356

Q37166129-ED587798-1741-4F42-9E0E-848EEE2B7C60

P407

Q37166129-85310A7B-46A7-4FC7-8E36-9BBC85BE0F8E

P433

Q37166129-D4206E7B-B7F1-4E63-A514-AC427397AE97

P478

Q37166129-C235C4C0-281A-404F-80E5-6701CCB3368F

P50

Q37166129-9031E541-78FD-43FA-9766-97BBDBF7DE9D

Q37166129-C2941D51-791F-421B-A40C-E5289E29A98B

P577

Q37166129-AD906DD3-8534-4C03-B9A8-429FF5463C24

P5875

Q37166129-6B2BFF74-2B8C-47BC-8174-3CD0CCF79325

P698

Q37166129-97460C11-3D0B-4B93-B752-73566B1FB11D

P921

Q37166129-9699A000-54AB-479E-ABA5-7A10172DDEC5

P932

Q37166129-9AB5CCF6-5D64-47DB-BE2E-EE2DA9F99449

P356

P1433

American Journal of Tropical Medicine and Hygiene

P1476

Serum levels of neopterin duri ...... cobacterium ulcerans infection

@en

P2093

Janine de Zeeuw

http://www.w3.org/2001/XMLSchema#string

K Mohammed Abass

http://www.w3.org/2001/XMLSchema#string

Sridevi Duggirala

http://www.w3.org/2001/XMLSchema#string

Willemien A Nienhuis

http://www.w3.org/2001/XMLSchema#string

Wilson Tuah

http://www.w3.org/2001/XMLSchema#string

Ymkje Stienstra

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.

Neopterin and procalcitonin are suitable biomarkers for exclusion of severe Plasmodium falciparum disease at the initial clinical assessment of travellers with imported malaria.

Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humans

Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.

Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection.

Systemic and local interferon-gamma production following Mycobacterium ulcerans infection.

Paradoxical responses after start of antimicrobial treatment in Mycobacterium ulcerans infection.

Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.

IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone.

Procalcitonin and neopterin correlation with aetiology and severity of pneumonia.

P304

498-500

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4269/AJTMH.12-0599

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P50

Tjip S van der Werf

P577

2013-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

247772694

http://www.w3.org/2001/XMLSchema#string

P698

23836576

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium ulcerans

P932

3771288

http://www.w3.org/2001/XMLSchema#string